Pregnancy-specific The last trimester of pregnancy and first six months of postnatal life are critical periods for the accumulation of the long-chain omega-3 PUFA, docosahexaenoic acid (DHA), in the brain and retina of the baby
12 CLINICAL PHARMACOLOGY CLINICAL PHARMACOLOGY SECTION 13 NONCLINICAL TOXICOLOGY NONCLINICAL TOXICOLOGY SECTION 14 CLINICAL STUDIES CLINICAL STUDIES SECTION 16 HOW SUPPLIED/STORAGE AND HANDLING HOW SUPPLIED SECTION WEGOVY Injection How Supplied WEGOVY injection is a clear, colorless solution available in cartons containing 4 single-dose pens, 4 single-dose syringes with integrated needles, or 1 single-patient-use pen (WEGOVY FlexTouch) as follows: Device Type Name Total Strength per Total Volume NDC Single-dose Pen WEGOVY 0.25 mg/0.5 mL 0169-4525-14 Single-dose Pen 0.5 mg/0.5 mL 0169-4505-14 Single-dose Pen 1 mg/0.5 mL 0169-4501-14 Single-dose Pen 1.7 mg/0.75 mL 0169-4517-14 Single-dose Pen 2.4 mg/0.75 mL 0169-4524-14 Single-dose Pen WEGOVY HD 7.2 mg/0.75 mL 0169-4572-14 Single-patient-use Pen (with 4 weekly doses of 2.4 mg) WEGOVY FlexTouch 9.6 mg/3 mL (3.2 mg/mL) 0169-4915-32 Single-dose Syringe WEGOVY 0.25 mg/0.5 mL 0169-1602-14 Single-dose Syringe 0.5 mg/0.5 mL 0169-1605-14 Single-dose Syringe 1 mg/0.5 mL 0169-1610-14 Single-dose Syringe 1.7 mg/0.75 mL 0169-1617-14 Single-dose Syringe 2.4 mg/0.75 mL 0169-1624-14 Recommended Storage Do not store WEGOVY in the freezer or directly adjacent to the refrigerator cooling element
[PubMed] [Google Scholar] 92.Wilmanski J., Siddiqi M., Deitch E
Better Blood Sugar Control: With increased insulin secretion and decreased glucose synthesis, semaglutide helps control blood sugar levels
By covalently binding to the toxic, reactive intermediates generated during Phase I metabolism, glutathione neutralizes these threats and renders them water-soluble for safe excretion
As mentioned above, tirzepatide hasnt been compared to the higher dose of semaglutide (Wegovy) now available
